Validating artificial intelligence effectiveness defined Lung nodule malignancy score in patients with pulmonary nodule.

Trial Identifier: D133FR00178
Sponsor: AstraZeneca
Start Date: April 2023
Primary Completion Date: December 2026
Study Completion Date: December 2026

Available Languages

For questions about your Trial Results Summary, please see Sponsor contact section within your Trial Results Summary.

No documents have been posted yet.

Trial Locations

Country Location
Egypt Alexandria, Egypt
India, Delhi New Delhi, Delhi, India, 110017
India, Delhi New Delhi, Delhi, India, 201012
India, Delhi New Delhi, Delhi, India, 110005
India, Haryana Gurugram, Haryana, India, 122001
India, India Bangalore, India, India, 560038
India, India Bangalore, India, India, 560011
India, India Chennai, India, India, 600026
India, India Chennai, India, India, 600116
India, India Chennai, India, India, 600045
India, India Chennai, India, India, 600053
India, India Chennai, India, India, 600040
India, India Kolkata, India, India, 700025
India, India Mumbai, India, India, 400069
India, India Pune, India, India, 411011
India, Telangana Hyderabad, Telangana, India, 500003
Indonesia, Indonesia Surabaya, Indonesia, Indonesia, 60286
Mexico, Mexico City Mexico City, Mexico, 6720
Mexico, Nuevo Leon Monterrey, Nuevo Leon, Mexico, 64460
Turkey, Turkey Ankara, Turkey, Turkey, 06100
Turkey, Turkey Mersin, Turkey, Turkey, 33010